12 commercial payer policies list J9118. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
12 policies from 12 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9118 |
|---|---|---|
| Asparagine Specific Enzymes (e.g., Rylaze, Asparlas, Oncaspar) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9118 |
|---|
| Oncology Medications | Jul 1, 2026 | Covered |
|---|
| Policy | Effective | Status of J9118 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9118 |
|---|---|---|
| ASPARLAS (RETIRED AS OF 02/4/2021) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Calaspargase Pegol-mknl (Asparlas) | May 31, 2019 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Pegaspargase (Oncaspar); Calaspargase pegol-mknl (Asparlas) CP.PHAR.353 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Erwinaze (Asparaginase Erwinia Chrysanthemi), Oncaspar (pegaspargase) and Asparlas (calaspargase pegol-mknl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9118 |
|---|---|---|
| Asparlas (calaspargase pegol-mknl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |